News

At the Consumer Electronics Show (CES) 2022 in Las Vegas, the Grenoble start-up Grapheal, represented by its CEO Vincent Bouchiat, was honoured.
It won the “Best in Innovation” award for its TestNPass technology, for its digital test strip that detects biomarkers and delivers an encrypted and time-stamped RFID tag. Graphene provides exceptional sensitivity within the digital test biosensor.

More information :

https://graphene-flagship.eu/graphene/news/grapheal-wins-prestigious-ces-2022-innovation-award/

https://www.ledauphine.com/science-et-technologie/2022/01/11/la-start-up-grenobloise-grapheal-fait-sensation-au-ces-de-las-vegas

https://actu.fr/economie/deux-entreprises-iseroises-recompensees-au-ces-de-las-vegas-2022_47800253.html

https://www.graphene-info.com/grapheal-wins-ces-2022-innovation-award



https://www.grapheal.com/

Grapheal is a Medtech spinoff of CNRS–Grenoble, France, producing connected biosensors coupled to mobile technologies. Grapheal brings connectivity to biosensing by designing embedded biosensors and wearables. Grapheal’s devices aim at providing solutions for field diagnostics and remote patient monitoring, with a focus on pathogen detection and woundcare. More on www.grapheal.com